# PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma

> **NCT04303117** · PHASE1,PHASE2 · RECRUITING · sponsor: **National Cancer Institute (NCI)** · enrollment: 80 (estimated)

## Conditions studied

- Kaposi Sarcoma

## Interventions

- **DRUG:** PDS01ADC
- **DRUG:** M7824

## Key facts

- **NCT ID:** NCT04303117
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-07-13
- **Primary completion:** 2028-12-01
- **Final completion:** 2028-12-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04303117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04303117, "PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04303117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*